Diabetes, dysglycemia and cognitive dysfunction

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 5, 2014, Pages 341-345

  Cukierman Yaffe, Tali ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cognitive dysfunction; Diabetes; Dysglycemia

Indexed keywords

INSULIN; RAMIPRIL; TELMISARTAN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN RECEPTOR;

CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DYSGLYCEMIA; HUMAN; HYPERGLYCEMIA; MICROANGIOPATHY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; AGED; ANATOMY AND HISTOLOGY; BRAIN; COGNITION; COGNITION DISORDERS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HYPOGLYCEMIA; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; SELF CARE;

AGED; BRAIN; COGNITION; COGNITION DISORDERS; DEMENTIA; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RECEPTOR, INSULIN; RISK FACTORS; SELF CARE;

EID: 84903726727     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2507     Document Type: Review

References (47)

1. Michel JP, Newton JL, Kirkwood TB. Medical challenges of improving the quality of a longer life. JAMA 2008; 299(6): 688-690.
2. Leveille SG, Guralnik JM, Ferrucci L, Langlois JA. Aging successfully until death in old age: opportunities for increasing active life expectancy. Am J Epidemiol 1999; 149(7): 654-664.
3. Proust-Lima C, Amieva H, Letenneur L, Orgogozo JM, Jacqmin-Gadda H, Dartigues JF. Gender and education impact on brain aging: a general cognitive factor approach. Psychol Aging 2008; 23(3): 608-620.
4. Proust-Lima C, Amieva H, Dartigues JF, Jacqmin-Gadda H. Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol 2007; 165(3): 344-350.
5. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia 2005; 48(12): 2460-2469.
6. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008; 7(2): 184-190.
7. Gregg EW, Yaffe K, Cauley JA et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.[see comment]. Arch Intern Med 2000; 160(2):174-180.
8. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004; 164(12): 1327-1333.
9. Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K. Diabetes impaired fasting glucose and development of cognitive impairment in older women. Neurology 2004; 63: 658-663.
10. Yaffe K, Blackwell TWR, Krueger K, Barrett CE. Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 2006; 10(4): 293-295.
11. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010; 26(7): 507-519.
12. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012; 379(9833): 2291-2299.
13. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64(4): 570-575.
14. Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis 2012; 30(Suppl 2): S185-S198.
15. Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013. DOI: 10.1093/epirev/mxs012
16. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012; 42(5): 484-491.
17. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001; 24(2): 366-370.
18. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39(11): 1392-1397.
19. Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44(2): 95-105.
20. MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cognit Disord 2002; 14(2): 77-83.
21. Biessels GJ. Sweet memories: 20years of progress in research on cognitive functioning in diabetes. Eur J Pharmacol 2013; 719(1-3): 153-160.
22. Small GW, Bookheimer SY, Thompson PM, et al. Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol 2008; 7(2): 161-172.
23. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 2003; 51(3): 410-414.
24. Schnaider BM, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004; 63(10): 1902-1907.
25. Shorr RI, de Rekeneire N, Resnick HE et al. Glycemia and cognitive function in older adults using glucose-lowering drugs. J Nutr Health Aging 2006; 10(4): 297-301.
26. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al. The Relationship between baseline glycemic control and cognitive function in people with type 2 diabetes and other cardiovascular risk factors: the ACCORD-MIND Study. Diabetes Care In press.
27. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013; 369(6): 540-548.
28. Cukierman-Yaffe T, Gerstein HC, Anderson C, et al. Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme. Diabetes Res Clin Pract 2009; 83(3): 387-393.
29. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009; 66(3): 324-328.
30. Sinclair A, Morley JE, Rodriguez-Manas L, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012; 13(6): 497-502.
31. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care 2012; 35(12): 2650-2664.
32. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000; 50(3): 203-212.
33. Bayer AJ, Johnston J, Sinclair AJ. Impact of dementia on diabetic care in the aged. J R Soc Med 1994; 87(10): 619-621.
34. de Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009; 52(11): 2328-2336.
35. Punthakee Z, Miller ME, Launer LJ, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012; 35(4): 787-793.
36. Horie K, Miyata T, Yasuda T, et al. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Comm 1997; 236(2): 327-332.
37. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. [Review] [132 refs]. Lab Invest 1994; 70(2): 138-51.
38. Wu W, Brickman AM, Luchsinger J, et al. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol 2008; 64(6): 698-706.
39. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. [Review] [171 refs]. Eur J Pharmacol 441(1-2):1-14, 2002.
40. Messier C. Glucose improvement of memory: a review. [Review] [232 refs]. Eur J Pharmacol 490(1-3):33-57, 2004.
41. Watson GS, Craft S. Modulation of memory by insulin and glucose: neurpsychological observations in Alzeimer's disease. Eur J Pharmacol 2004; 490: 97-113.
42. Messier C, Gagnon M. Glucose regulation and brain aging. [Review] [68 refs]. J Nutr Health Aging 4(4):208-13, 2000.
43. Messier C, Tsiakas M, Gagnon M, Desrochers A, Awad N. Effect of age and glucoregulation on cognitive performance. Neurobiol Aging 2003; 24(7): 985-1003.
44. Shemesh E, Rudich A, Harman-Boehm I, Cukierman-Yaffe T. Effect of intranasal insulin on cognitive function: a systematic review. J Clin Endocrinol Metab 2012; 97(2): 366-376.
45. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012; 69(1): 29-38.
46. Kohner EM. Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet Med 2008; 25(Suppl 2): 20-24.
47. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352(9131): 837-853.